|
PLEKHG3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.317600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.971720E-02 |
| Normal-vs-Stage2 |
6.110200E-01 |
| Normal-vs-Stage3 |
6.358800E-01 |
| Normal-vs-Stage4 |
2.001400E-01 |
| Stage1-vs-Stage2 |
1.221380E-01 |
| Stage1-vs-Stage3 |
2.233900E-02 |
| Stage1-vs-Stage4 |
4.192200E-01 |
| Stage2-vs-Stage3 |
9.085000E-01 |
| Stage2-vs-Stage4 |
5.373600E-01 |
| Stage3-vs-Stage4 |
3.890000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.181900E-02 |
| Normal-vs-AfricanAmerican |
1.559970E-01 |
| Normal-vs-Asian |
7.008100E-02 |
| Caucasian-vs-AfricanAmerican |
7.297800E-03 |
| Caucasian-vs-Asian |
8.405000E-01 |
| AfricanAmerican-vs-Asian |
1.798020E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.718400E-03 |
| Normal-vs-Female |
2.550800E-01 |
| Male-vs-Female |
9.115100E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.517110E-03 |
| Normal-vs-Age(41-60Yrs) |
5.484200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.241000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.018000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.238000E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.436000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.546200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.203600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.434400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.201600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.565400E-01 |
| Classical-VS-Follicular |
8.226400E-01 |
| Classical-VS-Other |
6.011400E-01 |
| Classical-VS-Normal |
1.154630E-01 |
| Tall-VS-Follicular |
2.962000E-01 |
| Tall-VS-Other |
3.342400E-01 |
| Tall-VS-Normal |
9.245000E-01 |
| Follicular-VS-Other |
7.021600E-01 |
| Follicular-VS-Normal |
1.267970E-01 |
| Other-VS-Normal |
2.202400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.392000E-02 |
| Normal-vs-N1 |
7.956700E-04 |
| N0-vs-N1 |
1.742130E-02 |
|
|
